Efficacy and safety of Sacituzumab govitecan in solid tumors: a systematic review and meta-analysis
{{output}}
Background: Sacituzumab govitecan (SG) is an antibody-drug conjugate (ADC) that targets trophoblast cell-surface antigen 2 and is conjugated to SN-38, a potent topoisomerase I inhibitor. SG has demonstrated promising activity aga... ...
